<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01418508</url>
  </required_header>
  <id_info>
    <org_study_id>ELPD-CKD</org_study_id>
    <nct_id>NCT01418508</nct_id>
  </id_info>
  <brief_title>Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease (CKD)- ELPD Study</brief_title>
  <acronym>ELPD-CKD</acronym>
  <official_title>Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease(CKD)- ELPD Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether low protein diet and very low protein diet
      supplemented keto-/amino acid is effective in preventing the progression of chronic kidney
      disease (CKD , stage 3b and 4).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dietary protein restriction represents a basic therapeutic approach in chronic kidney
      disease(CKD), by reducing the accumulation of nitrogen catabolic substances, and by delaying
      the progress of CKD and proteinuria, but the effects of the different degree's protein diet
      on the renal progression remain to be determined.

      The aim of this study is to evaluate the efficacy of low protein diet and α-keto acid tablet
      in retard the progress of CKD. This is a randomized, open-label, prospective study, 120
      patients who meet inclusion and exclusion criteria will be randomized into three groups at
      the ratio of 1:1:1. Group I patients will receive low protein diet(0.6g/kg BW), group II will
      receive low protein diet supplemented with α-keto acid, while group III will take very low
      protein diet(0.3g/kg BW) supplemented with α-keto acid. The changes of glomerular filtration
      rate in CKD will be evaluated after 1 year treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in glomerular filtration rate</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compliance to diet</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular morbidity</measure>
    <time_frame>1 year</time_frame>
    <description>Cardiovascular morbidity, defined by angina, heart failure, myocardial infarction, left ventricular mass, stroke, blood pressure, lipid profile, calcium/phosphorus/parathormone status and Charlson comorbidity index, at the start of dialysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>1 year</time_frame>
    <description>Nutritional status, defined by anthropo-plicometry, biochemistry, body bioimpedance analysis (BIA), subjective global nutritional assessment (SGA), at the start and during the 1st year of dialysis</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>low protein diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Behavioral: low protein diet 0.6g of proteins per kilo of body weight per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low protein diet plusα-keto acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.6g of proteins per kilo of body weight per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>very low protein diet plus α-keto acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.3g of proteins per kilo of body weight per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>low protein diet plus α-keto acid</intervention_name>
    <description>low protein diet plus α-keto acid 0.6g of proteins per kilo of body weight per day, supplemented with α-keto acid tablets</description>
    <arm_group_label>low protein diet plusα-keto acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>very low protein diet plus α-keto acid</intervention_name>
    <description>very low protein diet plus α-keto acid 0.3g of proteins per kilo of body weight per day, supplemented with α-keto acid tablets</description>
    <arm_group_label>very low protein diet plus α-keto acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic kidney disease in stage 3b and 4(15ml/min/1.73m2＜GFR＜45
             ml/min/1.73m2, estimated by EPI formula) receiving conservative treatment for CKD

        Exclusion Criteria:

          -  With diagnosis of diabetic mellitus;

          -  Incapable of following study requirements to control diet;

          -  Glomerular filtration rate &lt; 15 ml/min/1.73m2;

          -  Hypercalcemia or hyperkalemia (&gt; normal upper limit);

          -  Other serious disease(eg.heart,lung,brain) within the last 3 months;

          -  Cardiac failure stage IV NYHA;

          -  With cirrhosis of liver or obvious symptoms of liver diseases, ALT or AST two times
             normal upper limit;

          -  Severe edema or serous cavity effusion;

          -  Drug abuse;

          -  Final diagnosis of malignant tumor;

          -  Receiving the long-term systematic steroid hormone or immunosuppressive agents(eg.
             Cyclophosphamidum,Cyclosporine, Prograf,Azathioprine) treatment;

          -  Gestation already, prepares to be pregnant in the period of the trial, lactating
             women;

          -  Participate in other product clinical trial within 30 days prior to this trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xuemei Li, M.D.&amp; Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xuemei Li, M.D.&amp; Ph.D.</last_name>
    <phone>8610-65295058</phone>
    <email>0605.mei@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Limeng Chen, M.D.&amp; Ph.D.</last_name>
    <phone>8610-65295351</phone>
    <email>climeng2000@yahoo.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuemei Li, M.D.&amp; Ph.D.</last_name>
      <phone>8610-65295058</phone>
      <email>0605.mei@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Limeng Chen, M.D.&amp; Ph.D.</last_name>
      <phone>8610-65295351</phone>
      <email>climeng2000@yahoo.com.cn</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2011</study_first_submitted>
  <study_first_submitted_qc>August 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2011</study_first_posted>
  <last_update_submitted>August 16, 2011</last_update_submitted>
  <last_update_submitted_qc>August 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Xuemei Li</name_title>
    <organization>department of nephrology</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

